The Supplementary Notice on the Review and Approval of Drug Re-registration was issued on Sep.29, 2010. It aims to promote the re-registration of chemical drugs and multi-component biochemical drug injections, which includes relevant policies and regulations.
- Local Title:关于做好药品再注册审查审批工作的补充通知
- Country/Region:Chinese Mainland
- Competent Authority: Former China Food and Drug Administration (CFDA)
- Type:Notice
- Status:In force
- Release Date:2010-09-29
- Implementation Date:2010-09-29